Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk, a new study from Columbia researchers has found.
Sandoz launches ustekinumab biosimilar in Europe – Pharmaceutical Technology
An image of a patient with psoriasis. Sandoz’s ustekinumab biosimilar is indication for several autoimmune conditions including psoriasis. Image credit: Shutterstock/Fuss Sergey Sandoz has announced